Approval · Notice of Compliance 26326 · 2021
SOLENSIA: Notice of Compliance 26326
Issued July 27, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26326
- Date
- July 27, 2021
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLENSIA | 02518449 | Marketed |
Medicinal ingredients
- FRUNEVETMAB 7 MG per ML